Skip to main content
Erschienen in: Die Innere Medizin 2/2024

24.01.2024 | Schwerpunkt: Vaskulitiden

Sekundäre Vaskulitiden

verfasst von: Dr. med. Katharina Rose, Priv.-Doz. Dr. med. Christof Iking-Konert

Erschienen in: Die Innere Medizin | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Zusammenfassung

Vaskulitiden, die im Rahmen anderer zugrunde liegender Erkrankungen auftreten, werden als sekundäre Vaskulitiden bezeichnet. In der breiten Differenzialdiagnostik der Vaskulitiden ist eine Vielzahl sekundärer Vaskulitiden zu bedenken. Sekundäre Vaskulitiden sind im gesamten Spektrum der Vaskulitiden mit entsprechend vielfältiger klinischer Manifestation vertreten. Der vorliegende Beitrag bietet eine Übersicht von Systemerkrankungen und ätiologischen Faktoren, wie Infektionen, Medikamenten und Malignomen, die mit Vaskulitiden assoziiert sein können. Die Assoziationen mit infektiösen Erregern sind enorm breit gefächert und können hier nur in Ansätzen aufgezeigt werden, ohne Anspruch auf Vollständigkeit und schwerpunktmäßig aus westeuropäischer Perspektive. Insbesondere bei atypischen oder refraktären Verläufen empfiehlt sich die Reevaluation einer sekundären Genese. In Anbetracht der Vielfalt an Differenzialdiagnosen und der besonderen Herausforderung sekundärer Vaskulitiden ist die interdisziplinäre Zusammenarbeit für eine korrekte und frühzeitige Diagnose und für das therapeutische Management entscheidend. Im Vordergrund steht immer die Therapie der zugrunde liegenden Erkrankung bzw. die sofortige Beendigung der Medikation bei Verdacht auf eine medikamenteninduzierte Vaskulitis.
Literatur
1.
Zurück zum Zitat Agnello V et al (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327(21):1490–1495PubMedCrossRef Agnello V et al (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327(21):1490–1495PubMedCrossRef
2.
Zurück zum Zitat Argyropoulou OD, Tzioufas AG (2020) Common and rare forms of vasculitis associated with Sjögren’s syndrome. Curr Opin Rheumatol 32(1):21–28PubMedCrossRef Argyropoulou OD, Tzioufas AG (2020) Common and rare forms of vasculitis associated with Sjögren’s syndrome. Curr Opin Rheumatol 32(1):21–28PubMedCrossRef
3.
Zurück zum Zitat Bahrami S et al (2006) Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 142(2):155–161PubMedCrossRef Bahrami S et al (2006) Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 142(2):155–161PubMedCrossRef
4.
5.
Zurück zum Zitat Beydon M, French Vasculitis Study Group (FVSG), - (2022) Bartonella and Coxiella infections presenting as systemic vasculitis: case series and review of literature. Rheumatology 61(6):2609–2618PubMedCrossRef Beydon M, French Vasculitis Study Group (FVSG), - (2022) Bartonella and Coxiella infections presenting as systemic vasculitis: case series and review of literature. Rheumatology 61(6):2609–2618PubMedCrossRef
6.
Zurück zum Zitat Boleto G et al (2020) Cryoglobulinemia after the era of chronic hepatitis C infection. Semin Arthritis Rheum 50(4):695PubMedCrossRef Boleto G et al (2020) Cryoglobulinemia after the era of chronic hepatitis C infection. Semin Arthritis Rheum 50(4):695PubMedCrossRef
7.
Zurück zum Zitat Brouet JC et al (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57(5):775–788PubMedCrossRef Brouet JC et al (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57(5):775–788PubMedCrossRef
8.
Zurück zum Zitat Bulkley BH, Roberts WC (1973) Ankylosing spondylitis and aortic regurgitation: description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 48:1014–1027PubMedCrossRef Bulkley BH, Roberts WC (1973) Ankylosing spondylitis and aortic regurgitation: description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 48:1014–1027PubMedCrossRef
9.
Zurück zum Zitat Calabrese LH (2004) Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin Exp Rheumatol 22(6 Suppl 36):S87–S93PubMed Calabrese LH (2004) Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin Exp Rheumatol 22(6 Suppl 36):S87–S93PubMed
11.
Zurück zum Zitat Carrer M et al (2023) Retrospective multicenter study comparing infectious and noninfectious aortitis. Clin Infect Dis 76(3):e1369–e1378PubMedCrossRef Carrer M et al (2023) Retrospective multicenter study comparing infectious and noninfectious aortitis. Clin Infect Dis 76(3):e1369–e1378PubMedCrossRef
12.
13.
Zurück zum Zitat Choi HK et al (2000) Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis. Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43:405–413PubMedCrossRef Choi HK et al (2000) Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis. Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43:405–413PubMedCrossRef
14.
Zurück zum Zitat Crout TM et al (2019) Systemic vasculitis associated with immune check point inhibition: analysis and review. Curr Rheumatol Rep 21(6):28PubMedCrossRef Crout TM et al (2019) Systemic vasculitis associated with immune check point inhibition: analysis and review. Curr Rheumatol Rep 21(6):28PubMedCrossRef
15.
Zurück zum Zitat De Vita S et al (2012) A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 64(3):843–853PubMedCrossRef De Vita S et al (2012) A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 64(3):843–853PubMedCrossRef
16.
Zurück zum Zitat Fain O et al (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57(8):1473–1480PubMedCrossRef Fain O et al (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57(8):1473–1480PubMedCrossRef
17.
Zurück zum Zitat Fernandes SR et al (2000) Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum 30(1):33–46PubMedCrossRef Fernandes SR et al (2000) Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum 30(1):33–46PubMedCrossRef
18.
19.
Zurück zum Zitat Georgin-Lavialle S et al (2021) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol 186(3):564–574PubMedCrossRef Georgin-Lavialle S et al (2021) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol 186(3):564–574PubMedCrossRef
20.
Zurück zum Zitat Grau RG (2015) Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep 17(12):71PubMedCrossRef Grau RG (2015) Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep 17(12):71PubMedCrossRef
22.
Zurück zum Zitat Greco F et al (2007) Cutaneous vasculitis associated with mycoplasma pneumoniae infection: case report and literature review. Clin Pediatr (Phila) 46(5):451–453PubMedCrossRef Greco F et al (2007) Cutaneous vasculitis associated with mycoplasma pneumoniae infection: case report and literature review. Clin Pediatr (Phila) 46(5):451–453PubMedCrossRef
23.
Zurück zum Zitat Guellec D et al (2015) ANCA-associated vasculitis in patients with primary Sjogren’s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev 14(8):742–750PubMedCrossRef Guellec D et al (2015) ANCA-associated vasculitis in patients with primary Sjogren’s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev 14(8):742–750PubMedCrossRef
24.
Zurück zum Zitat Guillevin L et al (1995) Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 74(5):238–253PubMedCrossRef Guillevin L et al (1995) Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 74(5):238–253PubMedCrossRef
25.
Zurück zum Zitat Hellmich B et al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis: 2022–223764 Hellmich B et al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis: 2022–223764
26.
Zurück zum Zitat Hutson TE, Hoffman GS (2000) Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 13(6):417–423PubMedCrossRef Hutson TE, Hoffman GS (2000) Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 13(6):417–423PubMedCrossRef
27.
Zurück zum Zitat Ishii A et al (2011) Sarcoidosis with pulmonary hypertension exacerbated by Takayasu-like large vessel vasculitis. Pathol Int 61(9):546–550PubMedCrossRef Ishii A et al (2011) Sarcoidosis with pulmonary hypertension exacerbated by Takayasu-like large vessel vasculitis. Pathol Int 61(9):546–550PubMedCrossRef
28.
Zurück zum Zitat Jennette JC et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11PubMedCrossRef Jennette JC et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11PubMedCrossRef
29.
Zurück zum Zitat López-Sánchez C et al (2021) Levamisole-induced vasculopathy. JAMA Dermatol 157(3):338PubMedCrossRef López-Sánchez C et al (2021) Levamisole-induced vasculopathy. JAMA Dermatol 157(3):338PubMedCrossRef
30.
Zurück zum Zitat Mahr A et al (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, wegener’s granulomatosis, and churg-strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51(1):92–99PubMedCrossRef Mahr A et al (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, wegener’s granulomatosis, and churg-strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51(1):92–99PubMedCrossRef
31.
Zurück zum Zitat McGrath MM et al (2011) Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 6:2799–2805PubMedPubMedCentralCrossRef McGrath MM et al (2011) Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 6:2799–2805PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Meliou M et al (2020) Toxocariasis of the nervous system. Acta Parasitol 65(2):291–299PubMedCrossRef Meliou M et al (2020) Toxocariasis of the nervous system. Acta Parasitol 65(2):291–299PubMedCrossRef
34.
Zurück zum Zitat Mohan N et al (2004) Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 31(10):1955–1958PubMed Mohan N et al (2004) Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 31(10):1955–1958PubMed
35.
Zurück zum Zitat Muratore F et al (2022) VEXAS syndrome: a case series from a single-center cohort of italian patients with vasculitis. Arthritis Rheumatol 74(4):665–670PubMedPubMedCentralCrossRef Muratore F et al (2022) VEXAS syndrome: a case series from a single-center cohort of italian patients with vasculitis. Arthritis Rheumatol 74(4):665–670PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Ntatsaki E et al (2014) Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology 53(1):145–152PubMedCrossRef Ntatsaki E et al (2014) Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology 53(1):145–152PubMedCrossRef
38.
Zurück zum Zitat Obiorah IE et al (2021) Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv 5(16):3203–3215PubMedPubMedCentralCrossRef Obiorah IE et al (2021) Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv 5(16):3203–3215PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Pagnoux C et al (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24(2 Suppl 41):S71–S81PubMed Pagnoux C et al (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24(2 Suppl 41):S71–S81PubMed
40.
Zurück zum Zitat Palazzi C et al (2011) Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine 78(5):451–455PubMedCrossRef Palazzi C et al (2011) Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine 78(5):451–455PubMedCrossRef
41.
Zurück zum Zitat Pendergraft WF 3rd, Niles JL (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26(1):42–49PubMedCrossRef Pendergraft WF 3rd, Niles JL (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26(1):42–49PubMedCrossRef
42.
Zurück zum Zitat Quartuccio L et al (2023) Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC). Clin Rheumatol 42(2):359–370PubMedCrossRef Quartuccio L et al (2023) Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC). Clin Rheumatol 42(2):359–370PubMedCrossRef
43.
44.
Zurück zum Zitat Ramos-Casals M et al (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 86(4):242–251PubMedCrossRef Ramos-Casals M et al (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 86(4):242–251PubMedCrossRef
45.
Zurück zum Zitat Ramos-Casals M et al (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine 85(2):95–104PubMedCrossRef Ramos-Casals M et al (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine 85(2):95–104PubMedCrossRef
47.
Zurück zum Zitat Roupie AL et al (2020) Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. Semin Arthritis Rheum 50(5):879–884PubMedCrossRef Roupie AL et al (2020) Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. Semin Arthritis Rheum 50(5):879–884PubMedCrossRef
48.
Zurück zum Zitat Saint Marcoux B, De Bandt M CRI (Club Rhumatismes et Inflammation) (2006) vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73(6):710–713 Saint Marcoux B, De Bandt M CRI (Club Rhumatismes et Inflammation) (2006) vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73(6):710–713
49.
Zurück zum Zitat Sharma C et al (2021) Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 17(12):731–748PubMedPubMedCentralCrossRef Sharma C et al (2021) Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 17(12):731–748PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Solans-Laqué R et al (2008) Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35(2):294–304PubMed Solans-Laqué R et al (2008) Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35(2):294–304PubMed
52.
Zurück zum Zitat Stone JR et al (2015) Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24(5):267–278PubMedCrossRef Stone JR et al (2015) Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24(5):267–278PubMedCrossRef
53.
Zurück zum Zitat Ursini F et al (2023) Inflammatory rheumatic diseases with onset after SARS-CoV‑2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group. RMD Open 9(2):e3022PubMedCrossRef Ursini F et al (2023) Inflammatory rheumatic diseases with onset after SARS-CoV‑2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group. RMD Open 9(2):e3022PubMedCrossRef
55.
56.
Zurück zum Zitat Wiesner O et al (2004) Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50(9):2954–2965PubMedCrossRef Wiesner O et al (2004) Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50(9):2954–2965PubMedCrossRef
57.
Zurück zum Zitat Wilk A (2008) Drug-induced vasculitis. Curr Opin Rheumatol 20:35–39CrossRef Wilk A (2008) Drug-induced vasculitis. Curr Opin Rheumatol 20:35–39CrossRef
Metadaten
Titel
Sekundäre Vaskulitiden
verfasst von
Dr. med. Katharina Rose
Priv.-Doz. Dr. med. Christof Iking-Konert
Publikationsdatum
24.01.2024
Verlag
Springer Medizin
Erschienen in
Die Innere Medizin / Ausgabe 2/2024
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-023-01654-3

Weitere Artikel der Ausgabe 2/2024

Die Innere Medizin 2/2024 Zur Ausgabe

Schwerpunkt: Vaskulitiden

Immunglobulin-A-Vaskulitis

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.